glp 1 agonist effects GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes GLP-1 and Anesthesia: Considerations and
Description
Endocrinology (2004) 145:268795
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as highly effective therapies for weight reduction and glycemic control, and they show promise in improving fertility outcomes in women with obesity and PCOS [5,6]
Efficacy and safety of co-administered once-weekly cagrilintide 24 mg with once-weekly semaglutide 24 mg in type 2 diabetes: A multicentre, randomised, double-blind, active-controlled, phase 2 trial
Addressing these questions will be critical to optimizing the clinical and public health impact of GLP-1 RAs
